Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

Yi-Chun Lin,1 Shih-Wei Li,2 Shin-Yen Ku,3 Hui-Ting Hsieh,3 Mei-Hui Lin,3 Shu-Yin Chang,3 Wei-Wei Wu,3 Na-Lee Sun,3 Shu-Hsing Cheng,1,4 Chien-Yu Cheng1,51Department of Internal Medicine, Division of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan; 2...

Full description

Bibliographic Details
Main Authors: Lin YC, Li SW, Ku SY, Hsieh HT, Lin MH, Chang SY, Wu WW, Sun NL, Cheng SH, Cheng CY
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Infection and Drug Resistance
Subjects:
hepatitis C
grazoprevir and elbasvir
PEGylated interferon plus ribavirin
direct-acting antiviral
HCV genotype 1
HCV/HIV co-infection
Online Access:https://www.dovepress.com/grazoprevirelbasvir-in-peginterferon-alfa-plus-ribavirin-experienced-p-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/grazoprevirelbasvir-in-peginterferon-alfa-plus-ribavirin-experienced-p-peer-reviewed-article-IDR

Similar Items